The Patent Finder

Cyclacel Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Cyclacel Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 6 of 6 · Back to Cyclacel Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,133,199Pyrimidine derivatives as protein kinase inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,563,542Pyrimidine derivatives as protein kinase inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 6,403,555Depsipeptide and congeners thereof for use as immunosuppressants
Formerly held
Term ended
Term ended Dec 6, 2020 · From the USPTO record
Term endedTerm ended Dec 6, 2020From the USPTO record
US 6,548,479Depsipeptide and Congeners Thereof for Use as Immunosuppressants
Formerly held
Term ended
Term ended Dec 6, 2020 · Medium confidence
Term endedTerm ended Dec 6, 2020Medium confidence
US 6,828,302Therapeutic Uses of Depsipeptides and Congeners Thereof
Formerly held
Term ended
Ended no later than Dec 6, 2020 · Low confidence
Term endedEnded no later than Dec 6, 2020Low confidence
US 7,041,639Depsipeptide and Congeners Thereof for Use as Immunosuppressants
Formerly held
Lapsed on the fee record
Ended May 9, 2018 · Medium confidence
Lapsed on the fee recordEnded May 9, 2018Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited